Truist Financial’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Truist Financial’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.96M	Buy	+57,088	New	+$1.95M	﹤0.01%	1337
2023 Q2	–	Sell	-45,988	Closed	-$1.2M	–	2598
2023 Q1	$1.2M	Sell	45,988 -182,383	-80%	-$4.89M	﹤0.01%	1467
2022 Q4	$6.26M	Buy	228,371 +8,297	+4%	+$221K	0.01%	742
2022 Q3	$5.29M	Buy	220,074 +165,207	+301%	+$4.27M	0.01%	762
2022 Q2	$1.45M	Buy	54,867 +34,737	+173%	+$918K	﹤0.01%	1378
2022 Q1	$536K	Buy	+20,130	New	+$520K	﹤0.01%	1970

Other funds holding FTXH

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Truist Financial's FTXH Position: Q1 2026 in Review

Truist Financial opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2026: 57,088 shares worth $1.96M. The stake represents ﹤0.01% of the portfolio and ranks #1337 among its holdings. This is a return to the name: Truist Financial previously reported a position in FTXH as recently as Q1 2023.

Truist Financial first reported a position in FTXH in Q1 2022 and has held it in 6 quarters since. The position peaked at $6.26M in Q4 2022. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

Truist Financial held 57,088 shares of First Trust Nasdaq Pharmaceuticals ETF worth $1.96M as of Q1 2026.
First Trust Nasdaq Pharmaceuticals ETF was a new Truist Financial position in Q1 2026.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Truist Financial's portfolio in Q1 2026, its #1337 holding.
Truist Financial first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q1 2022 and has held it in 6 quarters since.
Truist Financial's First Trust Nasdaq Pharmaceuticals ETF position peaked at $6.26M in Q4 2022.
32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.